S Push. Show Affiliations »
Abstract
Entities: Gene
Mesh： See more » Cost-Benefit AnalysisGaucher Disease/drug therapyGaucher Disease/economicsGlucosylceramidase/economicsGlucosylceramidase/therapeutic useHumansTreatment Outcome
Substances： See more » algluceraseGlucosylceramidase
Year: 1995 PMID： 10155316 DOI： 10.2165/00019053-199507030-00010
Source DB: PubMed Journal: Pharmacoeconomics ISSN： 1170-7690 Impact factor: 4.981